Soligenix SNGX
NASDAQ SNGX
$0.40 +0.02 (+5.50%)
At close: Aug 21, 2026 · 4:00 PM EDT

Soligenix (SNGX) Cash & Current Investments (2010 - 2026)

Soligenix's (SNGX) quarterly Cash & Current Investments came in at $6.0 million in Q1 2026, down 17.37% YoY from $7.3 million in Q1 2025, and down 24.03% on a QoQ basis from $7.9 million in Q4 2025.

Soligenix (SNGX) Cash & Current Investments (2010 - 2026) Analysis & Trends

Soligenix (SNGX) has 17 years of Cash & Current Investments data on file, last reported at $6.0 million in Q1 2026.

  • Quarterly Cash & Current Investments fell 17.37% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (down 17.37% YoY) and the FY2025 annual result came in at $7.9 million, up 1.49% from the prior year.
  • Cash & Current Investments slipped to $6.0 million in Q1 2026, from $7.9 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $22.9 million in Q1 2022 to a low of $5.1 million in Q2 2025.
  • A 5-year average of $11.0 million and a median of $9.8 million in 2024 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2023 — Cash & Current Investments slumped 55.12% — and 2025, when it increased 6.96%.
  • Tracing SNGX's Cash & Current Investments over 5 years: stood at $13.4 million in 2022, then tumbled by 36.78% to $8.4 million in 2023, then retreated by 7.42% to $7.8 million in 2024, then grew by 1.49% to $7.9 million in 2025, then fell by 24.03% to $6.0 million in 2026.
  • The last three Cash & Current Investments figures came in at $6.0 million (Q1 2026), $7.9 million (Q4 2025), and $10.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 Soligenix 6.45 Mn 6.45 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2026 9.81 Mn
Mar 31, 2026 6.03 Mn
Dec 31, 2025 7.94 Mn
Sep 30, 2025 10.53 Mn
Jun 30, 2025 5.10 Mn
Mar 31, 2025 7.30 Mn
Dec 31, 2024 7.82 Mn
Sep 30, 2024 9.84 Mn
Jun 30, 2024 9.41 Mn
Mar 31, 2024 7.09 Mn
Dec 31, 2023 8.45 Mn
Sep 30, 2023 10.30 Mn
Jun 30, 2023 13.16 Mn
Mar 31, 2023 10.27 Mn
Dec 31, 2022 13.36 Mn
Sep 30, 2022 16.87 Mn
Jun 30, 2022 20.16 Mn
Mar 31, 2022 22.88 Mn
Dec 31, 2021 26.04 Mn
Sep 30, 2021 28.87 Mn